Efficacy and Safety of Tranexamic Acid Combined with Rivaroxaban in Primary Total Knee Arthroplasty: A Meta-Analysis of Randomized Controlled Trials

References

• Karam JA, Bloomfield MR, Diiorio TM, et al. Evaluation of the efficacy and safety of tranexamic acid for reducing blood loss in bilateral total knee arthroplasty. J Arthroplast. 2014;29(3):501–503. doi:10.1016/j.arth.2013.08.005.
   PubMed Web of Science ®Google Scholar
• Finnegan MA, Shaffer R, Remington A, et al. Emergency department visits following elective total hip and knee replacement surgery: identifying gaps in continuity of care. J Bone Joint Surg Am. 2017;99(12):1005–1012. doi:10.2106/JBJS.16.00692.
   PubMed Web of Science ®Google Scholar
• Chang-Jiang WU, Wei LI, Xiao-Dong G. Clinical analysis of total knee arthroplasty on the treatment of rheumatoid arthritis. Prog Mod Biomed. 2015, 80(6):983–989.
   Google Scholar
• Xie J, Ma J, Kang P, et al. Does tranexamic acid alter the risk of thromboembolism following primary total knee arthroplasty with sequential earlier anticoagulation? A large, single center, prospective cohort study of consecutive cases. Thromb Res. 2015;136(2):234–238. doi:10.1016/j.thromres.2015.05.014.
   PubMed Web of Science ®Google Scholar
• Gylvin SH, Jørgensen CC, Fink-Jensen A, et al. Psychopharmacologic treatment and blood transfusion in fast-track total hip and knee arthroplasty. Transfusion. 2017;57(4):971–976. doi:10.1111/trf.13992.
   PubMed Web of Science ®Google Scholar
• Nishihara S, Hamada M. Does tranexamic acid alter the risk of thromboembolism after total hip arthroplasty in the absence of routine chemical thromboprophylaxis? Bone Joint J. 2015;97(4):458–462. doi:10.1302/0301-620X.97B4.34656.
   PubMedGoogle Scholar
• Chelly JE, Metais B, Schilling D, et al. Combination of superficial and deep blocks with rivaroxaban. Pain Med. 2015;16(10):2024–2030. doi:10.1111/pme.12801.
   PubMed Web of Science ®Google Scholar
• Yen SH, Lin PC, Kuo FC, et al. Thromboprophylaxis after minimally invasive total knee arthroplasty: a comparison of rivaroxaban and enoxaparin. Biomed J. 2014;37(4):199–204. doi:10.4103/2319-4170.125627.
   PubMedGoogle Scholar
• Yen SH, Lin PC, Chen B, et al. Topical tranexamic acid reduces blood loss in minimally invasive total knee arthroplasty receiving rivaroxaban. BioMed Res Int. 2017;2017:9105645. doi:10.1155/2017/9105645.
   PubMed Web of Science ®Google Scholar
• Wang JW, Chen B, Lin PC, et al. The efficacy of combined use of rivaroxaban and tranexamic acid on blood conservation in minimally invasive total knee arthroplasty a double-blind randomized, controlled trial. J Arthroplast. 2017;32(3):801–806. doi:10.1016/j.arth.2016.08.020.
   PubMed Web of Science ®Google Scholar
• Hourlier H, Fennema P. Tranexamic acid use and risk of thrombosis in regular users ofantithrombotics undergoing primary total knee arthroplasty: a prospective cohort study. Blood Transfus. 2018;16(1):44–52. doi:10.2450/2016.0160-16.
   PubMed Web of Science ®Google Scholar
• Lin SY, Chen CH, Fu YC, et al. The efficacy of combined use of intraarticular and intravenous tranexamic acid on reducing blood loss and transfusion rate in total knee arthroplasty. J Arthroplast. 2015;30(5):776–780. doi:10.1016/j.arth.2014.12.001.
   PubMed Web of Science ®Google Scholar
• Kim YT, Wook KM, Kyu LJ, et al. Combined use of topical intraarticular tranexamic acid and rivaroxaban in total knee arthroplasty safely reduces blood loss, transfusion rates, and wound complications without increasing the risk of thrombosis. BMC Musculoskelet Disord. 2018;19(1):227. doi:10.1186/s12891-018-2151-2.
   PubMedGoogle Scholar
• Abdullah HR, Sim YE, Hao Y, et al. Association between preoperative anaemia with length of hospital stay among patients undergoing primary total knee arthroplasty in Singapore: a single-centre retrospective study. BMJ Open. 2017;7(6):e016403. doi:10.1136/bmjopen-2017-016403.
   PubMed Web of Science ®Google Scholar
• Dowsey MM, Scott A, Nelson EA, et al. Using discrete choice experiments as a decision aid in total knee arthroplasty: study protocol for a randomised controlled trial. Trials. 2016;17(1):416. doi:10.1186/s13063-016-1536-5.
   PubMedGoogle Scholar
• Naouar N, Kaziz H, Mouelhi T, et al. Evaluation at long term follow up of medial unicompartmental knee arthroplasty in young patients. Tunis Med. 2016;94(1):66–71.
   PubMedGoogle Scholar
• Park YB, Chae WS, Park SH, et al. Comparison of short-term complications of general and spinal anesthesia for primary unilateral total knee arthroplasty. Knee Surg Relat Res. 2017;29(2):96–103. doi:10.5792/ksrr.16.009.
   PubMedGoogle Scholar
• Anderson NJ, Dowsey MM, Choong PFM. Effect of re-transfusion systems on physiotherapy participation and transfusion in total knee joint arthroplasty. ANZ J Surg. 2016;86(11):916–920. doi:10.1111/ans.13259.
   PubMed Web of Science ®Google Scholar
• Hamilton TW, Strickland LH, Pandit HG. A meta-analysis on the use of gabapentinoids for the treatment of acute postoperative pain following total knee arthroplasty. J Bone Joint Surg Am. 2016;98(16):1340–1350. doi:10.2106/JBJS.15.01202.
   PubMed Web of Science ®Google Scholar
• Öztaş S, Öztürk A, Akalin Y, et al. The effect of local and systemic application of tranexamic acid on the amount of blood loss and allogeneic blood transfusion after total knee replacement. Acta Orthop Belg. 2015;81(4):698–707.
   PubMed Web of Science ®Google Scholar
• Nichols CI, Vose JG. Comparative risk of transfusion and incremental total hospitalization cost for primary unilateral, bilateral, and revision total knee arthroplasty procedures. J Arthroplasty. 2016;31(3):583–589.e1. doi:10.1016/j.arth.2015.10.013.
   PubMed Web of Science ®Google Scholar
• Kim TK, Chang CB, Koh IJ. Practical issues for the use of tranexamic acid in total knee arthroplasty: a systematic review. Knee Surg Sports Traumatol Arthrosc. 2014;22(8):1849–1858. doi:10.1007/s00167-013-2487-y.
   PubMed Web of Science ®Google Scholar
• Pagnotta G, Rich E, Eckardt P, et al. The effect of a rapid rehabilitation program on patients undergoing unilateral total knee arthroplasty. Orthop Nurs. 2017;36(2):112–121. doi:10.1097/NOR.0000000000000325.
   PubMed Web of Science ®Google Scholar
• Schaal T, Schoenfelder T, Klewer J, et al. Effects of perceptions of care, medical advice, and hospital quality on patient satisfaction after primary total knee replacement: a cross-sectional study. PLoS One. 2017;12(6):e0178591. doi:10.1371/journal.pone.0178591.
   PubMed Web of Science ®Google Scholar
• Churchill JL, Toney VA, Truchan S, et al. Using aminocaproic acid to reduce blood loss after primary unilateral total knee arthroplasty. Am J Orthop. 2016;45(5):E245–E248.
   PubMedGoogle Scholar
• Maempel JF, Wickramasinghe NR, Clement ND, et al. The pre-operative levels of haemoglobin in the blood can be used to predict the risk of allogenic blood transfusion after total knee arthroplasty. Bone Joint J. 2016;98(4):490–497. doi:10.1302/0301-620X.98B4.36245.
   PubMedGoogle Scholar
• Pannucci CJ, Cuker A. Commentary on: rivaroxaban for venous thromboembolism prophylaxis in abdominoplasty: a multicenter experience. Aesthet Surg J. 2016;36(1):67–70. doi:10.1093/asj/sjv129.
   PubMed Web of Science ®Google Scholar
• Pertlíček J, Stehlík J, Sadovský P, et al. The effect of tranexamic acid on blood loss after primary unilateral total knee arthroplasty. prospective single-centre study. Acta Chir Orthop Traumatol Cech. 2015;82(6):418–423.
   PubMed Web of Science ®Google Scholar
• Mao Z, Yue B, Wang Y, et al. A comparative, retrospective study of peri-articular and intra-articular injection of tranexamic acid for the management of postoperative blood loss after total knee arthroplasty. BMC Musculoskelet Disord. 2016;17(1):438. doi:10.1186/s12891-016-1293-3.
   PubMedGoogle Scholar
• Guzel Y, Gurcan OT, Golge UH, et al. Topical tranexamic acid versus autotransfusion after total knee arthroplasty. J Orthop Surg. 2016;24(2):179–182. doi:10.1177/1602400212.
   Web of Science ®Google Scholar
• Uğurlu M, Aksekili MAE, Çağlar C, et al. Effect of topical and intravenously applied tranexamic acid compared to control group on bleeding in primary unilateral total knee arthroplasty. J Knee Surg. 2016;30(2):152–157. doi:10.1055/s-0036-1583270.
   PubMed Web of Science ®Google Scholar
• Zou Y, Tian S, Wang Y, et al. Administering aspirin, rivaroxaban and low-molecular-weight heparin to prevent deep venous thrombosis after total knee arthroplasty. Blood Coagul Fibrinolysis. 2014;25(7):660–664. doi:10.1097/MBC.0000000000000121.
   PubMed Web of Science ®Google Scholar
• Gómez-Outes A, Terleira-Fernández AI, Suárez-Gea ML, et al. Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons. BMJ. 2012;344:e3675. doi:10.1136/bmj.e3675.
   PubMed Web of Science ®Google Scholar
• Subramanyam KN, Khanchandani P, Tulajaprasad PV, et al. Efficacy and safety of intra-articular versus intravenous tranexamic acid in reducing perioperative blood loss in total knee arthroplasty: a prospective randomized double-blind equivalence trial. Bone Joint J. 2018; 100(2):152–160. doi:10.1302/0301-620X.100B2.BJJ-2017-0907.R1.
   PubMedGoogle Scholar
• George J, Eachempati KK, Subramanyam KN, et al. The comparative efficacy and safety of topical and intravenous tranexamic acid for reducing perioperative blood loss in Total knee arthroplasty – a randomized controlled non-inferiority trial. Knee. 2018;25(1):185–191. doi:10.1016/j.knee.2017.11.006.
   PubMed Web of Science ®Google Scholar